H.B. Fuller (NYSE:FUL) Sets New 12-Month Low – Here’s What Happened

H.B. Fuller (NYSE:FUL)’s stock price hit a new 52-week low during trading on Wednesday . The stock traded as low as $60.73 and last traded at $61.45, with a volume of 38676 shares trading hands. The stock had previously closed at $61.30.

Analysts Set New Price Targets

FUL has been the subject of a number of research reports. JPMorgan Chase & Co. dropped their price target on H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating for the company in a research note on Friday, January 17th. Vertical Research downgraded H.B. Fuller from a “buy” rating to a “hold” rating in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft lowered their price objective on H.B. Fuller from $75.00 to $72.00 and set a “buy” rating for the company in a research report on Wednesday, January 22nd. Finally, Citigroup cut their target price on H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $75.60.

H.B. Fuller Trading Down 1.1 %

The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.16 and a current ratio of 1.81. The firm has a market capitalization of $3.31 billion, a P/E ratio of 26.18, a PEG ratio of 1.21 and a beta of 1.42. The firm has a 50 day simple moving average of $67.05 and a two-hundred day simple moving average of $75.06.

H.B. Fuller (NYSE:FUL) last posted its quarterly earnings data on Wednesday, January 15th. The specialty chemicals company reported $0.92 EPS for the quarter, missing the consensus estimate of $1.00 by ($0.08). The firm had revenue of $923.00 million during the quarter, compared to analysts’ expectations of $916.84 million. H.B. Fuller had a net margin of 3.65% and a return on equity of 12.01%. The company’s quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter last year, the business posted $1.32 EPS. Equities research analysts forecast that H.B. Fuller will post 4.07 earnings per share for the current year.

H.B. Fuller Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, February 20th. Shareholders of record on Thursday, February 6th will be paid a $0.2225 dividend. The ex-dividend date is Thursday, February 6th. This represents a $0.89 annualized dividend and a dividend yield of 1.47%. H.B. Fuller’s payout ratio is presently 38.53%.

Institutional Trading of H.B. Fuller

A number of institutional investors have recently modified their holdings of the business. Geode Capital Management LLC grew its position in shares of H.B. Fuller by 1.5% in the third quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock valued at $99,939,000 after purchasing an additional 18,734 shares in the last quarter. Lord Abbett & CO. LLC boosted its stake in H.B. Fuller by 79.8% in the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock worth $57,952,000 after purchasing an additional 324,056 shares during the period. Bank of New York Mellon Corp grew its holdings in H.B. Fuller by 17.2% during the 4th quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company’s stock valued at $37,448,000 after buying an additional 81,558 shares in the last quarter. S&CO Inc. increased its position in shares of H.B. Fuller by 0.3% during the third quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock valued at $21,209,000 after buying an additional 920 shares during the period. Finally, Amundi lifted its holdings in shares of H.B. Fuller by 191.9% in the fourth quarter. Amundi now owns 28,553 shares of the specialty chemicals company’s stock worth $1,804,000 after buying an additional 18,771 shares in the last quarter. 95.93% of the stock is currently owned by hedge funds and other institutional investors.

About H.B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.